Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000388280 | SCV000471226 | likely benign | Occult macular dystrophy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004659016 | SCV005156146 | uncertain significance | Inborn genetic diseases | 2024-05-10 | criteria provided, single submitter | clinical testing | The c.1007C>T (p.T336M) alteration is located in exon 4 (coding exon 3) of the RP1L1 gene. This alteration results from a C to T substitution at nucleotide position 1007, causing the threonine (T) at amino acid position 336 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |